Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-02 04:07:46 - browse：887

An ALS patient receives support. -- health coverage from STAT — Adobe

Years of polarizing scientific discourse and bruising online debate will come to a head next week when advisers to the Food and Drug Administration weigh in on NurOwn, a potential treatment to slow the progression of ALS that has bitterly divided physicians and patient advocates.

On Sept. 27, a panel of experts will consider the convoluted data supporting the potential approval of NurOwn, a stem-cell therapy the FDA previously refused to even consider. To some physicians, the drug’s failure to show significant benefits in clinical studies leaves approval out of the question. Others, including the influential ALS Association, say NurOwn’s manufacturer, a small biotech firm called BrainStorm Cell Therapeutics, hasn’t disclosed enough information to properly determine the medicine’s value.

Another group of patients and doctors argue that NurOwn’s supporting evidence, while problematic, justifies making it available to the roughly 30,000 ALS patients in the U.S., people for whom there is currently no hope of arresting an incurable disease that gradually erodes motor function and leads to death within about five years of diagnosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Exact Sciences stock tumbles despite strong cancer detection sales

knowledge

WSS

Head of FDA's diagnostics center, who led through Covid, retires

Cell therapy fails to slow type 1 diabetes, but safety is established

Cardiologists urge adding sexual orientation, gender identity to health records

Why rehabilitation engineers need to center patients in their research

What causes osteoarthritis? Researchers study link to brain protein

What causes osteoarthritis? Researchers study link to brain protein

explore

Wikipedia

Wikipedia

Virginia high school admissions case could be legal follow

High breast density mammograms need follow

Wildfire smoke exposes gaps in outdoor worker protections

Head of FDA's diagnostics center, who led through Covid, retires

New air purifier tech could be key to improving indoor air quality

Medicare drug price lawsuits could be good politics for Biden

Peter Hotez and the public health issue of online harassment

Microsoft launches AI tool for clinical documentation through Epic

Virginia high school admissions case could be legal follow

What causes osteoarthritis? Researchers study link to brain protein

leisure time

More tobacco lobbyists active in statehouses

Orangutan used medicinal plant to treat wound, first time ever seen

Mass General, Mayo Clinic look to monetize custom

Flu vaccine reformulation won't be easy, manufacturers warn

CVS is on a mission to consolidate health care. Will it work?

Immunocompromised patients offer clues on chronic Covid

focus

hotspot

knowledge

knowledge